Rip2 modifies VEGF-induced signalling and vascular permeability in myocardial ischaemia-Reference-Cited by-同舟云学术

Rip2 modifies VEGF-induced signalling and vascular permeability in myocardial ischaemia

Published:2015-06-30 Issue:4 Volume:107 Page:478-486
ISSN:0008-6363
Container-title:Cardiovascular Research
language:en
Short-container-title:Cardiovasc Res

Author:

Andersson Linda,Scharin Täng Margareta,Lundqvist Annika,Lindbom Malin,Mardani Ismena,Fogelstrand Per,Shahrouki Puja,Redfors Björn,Omerovic Elmir,Levin Max,Borén Jan,Levin Malin C.

Funder

Swedish Research Council

Swedish Heart and Lung Foundation

Swedish Foundation for Strategic Research

Sahlgrenska University Hospital

Publisher

Oxford University Press (OUP)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine,Physiology

Link

http://academic.oup.com/cardiovascres/article-pdf/107/4/478/17195162/cvv186.pdf

Reference33 articles.

1. Signal transduction by vascular endothelial growth factor receptors

2. Pathophysiological consequences of VEGF-induced vascular permeability

3. Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart

4. Toll-like receptor 3 plays a role in myocardial infarction and ischemia/reperfusion injury

5. Reduced Myocardial Ischemia-Reperfusion Injury in Toll-Like Receptor 4-Deficient Mice

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RIPK2 inhibitors for disease therapy: Current status and perspectives;European Journal of Medicinal Chemistry;2023-11

2. Receptor Interacting Ser/Thr-Protein Kinase 2 as a New Therapeutic Target;Journal of Medicinal Chemistry;2023-10-19

3. Saikosaponin A protects against uremic toxin indole‑3 acetic acid‑induced damage to the myocardium;Molecular Medicine Reports;2023-07-06

4. Deficiency of miR-409-3p improves myocardial neovascularization and function through modulation of DNAJB9/p38 MAPK signaling;Molecular Therapy - Nucleic Acids;2023-06

5. RIP2 inhibition alleviates lipopolysaccharide-induced septic cardiomyopathy via regulating TAK1 signaling;European Journal of Pharmacology;2023-05